Is HIV testing during labor feasible?

	Tweet

Cameroon is a sub-Saharan African country with high HIV rates yet many pregnant women do not know their HIV status. Research published in the open access journal BMC Pregnancy and Childbirth has shown that HIV testing during labour is a suitable way of improving detection rates and may help mothers and their infants receive appropriate antiretroviral treatment.

Eugene Kongnyuy of the Liverpool School of Tropical Medicine and his collaborators from the University of Yaounde I, Cameroon, investigated the acceptability of rapid HIV testing among 2413 women of unknown HIV status at four hospitals in the capital city, Yaounde. They found that 88.3% of the women were willing to accept HIV testing during labour. Furthermore, their study revealed a higher rate of HIV infection among women screened during labour (10.1%) than was previously estimated in a national health survey (6.8%) which, according to the authors, highlights the importance of HIV testing during labour.

About 3.2 million infants and young children worldwide are infected with HIV and in most cases the infection is a consequence of mother-to-child transmission (MTCT).

Rapid HIV testing during labour or delivery represents the last opportunity for treatment before delivery to reduce MTCT. While this investigation has shown that HIV testing in the delivery room is feasible, it is nevertheless a challenging task especially in resource-constraint settings. The authors recommend “an opt-out approach for HIV testing during labour in Cameroon (i.e. women are informed that HIV testing will be routine during labour if HIV status is unknown but each person may decline to be tested). Such an approach will decrease the proportion of women who give birth with unknown HIV status and increase the number of mother-infant pairs who receive appropriate treatment for preventing MTCT of HIV”.

The team propose that cost-effectiveness of HIV counselling and testing during labour is evaluated before the approach is implemented nationwide.

###

Notes to Editors:

1. Acceptability of intrapartum HIV counselling and testing in Cameroon
Eugene Kongnyuy, Enow Mbu, Francois Mbopi-Keou, Nelson Fomulu, Philip Nana, Pierre Tebeu, Rebecca Tonye and Robert Leke
BMC Pregnancy and Childbirth (in press)

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central’s open access policy.

Article citation and URL available on request at on the day of publication.

2. BMC Pregnancy and Childbirth is an open access journal publishing original peer-reviewed research articles in all aspects of pregnancy and childbirth. BMC Pregnancy and Childbirth (ISSN 1471-2393) is indexed/tracked/covered by PubMed, MEDLINE, CAS, Scopus, EMBASE and Google Scholar.

3. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

Contact: Charlotte Webber

44-020-763-19980
BioMed Central

RELATED STORIES:
FDA Advisory Panel Approves Home HIV Test Kit   FDA Approves New In-Home HIV Test   Home HIV test advances   Survey Reveals Support for Over-the Counter HIV Testing   F.D.A. Panel Weighs Preventive Use of H.I.V. Drug   Stem Cell Therapy Shows Promise in Fight Against HIV   Progress against HIV thwarted by patients’ unmet needs   California to test pill for HIV prevention   Mechanism of HIV spread has potential for future drug therapy   Seeking HIV treatment clues in the neem tree   HIV Prevention Pill’s Value Varies by Target   Using AIDS drugs to prevent infection: a bargain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]